Enanta Pharmaceuticals (ENTA) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to -$0.42.
- Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) rose 6000.0% to -$0.42 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.21, marking a year-over-year increase of 3515.15%. This contributed to the annual value of -$3832.8 for FY2025, which is 6984193.02% down from last year.
- Per Enanta Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.42 for Q4 2025, which was up 6000.0% from -$871.2 recorded in Q3 2025.
- In the past 5 years, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of -$0.42 during Q4 2025, and its lowest value of -$871.2 during Q3 2025.
- Over the past 5 years, Enanta Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$1.35 (recorded in 2023), while the average stood at -$44.79.
- In the last 5 years, Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 9991.71% in 2021 and then tumbled by 6395908.82% in 2025.
- Quarter analysis of 5 years shows Enanta Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$1.48 in 2021, then rose by 6.08% to -$1.39 in 2022, then dropped by 13.67% to -$1.58 in 2023, then skyrocketed by 33.54% to -$1.05 in 2024, then soared by 60.0% to -$0.42 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.42 for Q4 2025, versus -$871.2 for Q3 2025 and -$0.85 for Q2 2025.